Cargando…
The ethical case for placebo control in HIV-cure-related studies with ART interruption
Many studies that seek to cure HIV must ask participants to interrupt their antiretroviral treatment. In such circumstances, is it permissible to include a placebo group in the study? We explain why doing so is a scientific and an ethical necessity, and more benign than imagined.
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464947/ https://www.ncbi.nlm.nih.gov/pubmed/36106155 http://dx.doi.org/10.1016/j.jve.2022.100084 |